pcs6422
·Code: PCS6422
pcs6422: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | Phase 2 |
Clinical Trials (1)
A Phase 2, Open-Label Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Frequently asked questions
Who is developing pcs6422?
pcs6422 is being developed by Processa Pharmaceuticals, Inc..
How many clinical trials involve pcs6422?
BioSniper tracks 1 clinical trial involving pcs6422.
Get deeper analysis on pcs6422
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis